Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsu Hayashida

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
Breast Cancer (Tokyo, Japan)|October 1, 2024
A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancerYuko Kawai, Aiko Nagayama, Kazuhiro Miyao, et al.
Breast Cancer Research and Treatment|July 10, 2019
Salivary metabolomics with alternative decision tree-based machine learning methods for breast cancer discriminationTakeshi Murata, Takako Yanagisawa, Toshiaki Kurihara, et al.
Neuropsychiatric Disease and Treatment|October 19, 2017
Self-rated cognitive functions following chemotherapy in patients with breast cancer: a 6-month prospective studyRyosuke Kitahata, Shinichiro Nakajima, Hiroyuki Uchida, et al.
Cancer Science|November 1, 2011
Direct inhibition of the transforming growth factor-β pathway by protein-bound polysaccharide through inactivation of Smad2 signalingYoshihiro Ono, Tetsu Hayashida, Ayano Konagai, et al.
Cancer Treatment Reviews|November 12, 2017
The updated network meta-analysis of neoadjuvant therapy for HER2-positive breast cancerAyako Nakashoji, Tetsu Hayashida, Takamichi Yokoe, et al.
Molecular Cancer|June 3, 2014
Bevacizumab terminates homeobox B9-induced tumor proliferation by silencing microenvironmental communicationYoshinori Hoshino, Tetsu Hayashida, Akira Hirata, et al.
Cancer Research|December 4, 2010
The integrin alpha(v)beta(3-5) ligand MFG-E8 is a p63/p73 target gene in triple-negative breast cancers but exhibits suppressive functions in ER(+) and erbB2(+) breast cancersChuanwei Yang, Tetsu Hayashida, Nicole Forster, et al.
Clinical Case Reports|August 28, 2018
IgG4-related mastopathy: A case report and literature reviewTakamichi Yokoe, Tetsu Hayashida, Masayuki Kikuchi, et al.
Surgery|July 2, 2011
The influence of donor age on liver regeneration and hepatic progenitor cell populationsYoshihiro Ono, Shigeyuki Kawachi, Tetsu Hayashida, et al.
Molecular and Clinical Oncology|July 14, 2022
Comparison between a new assay system, Elecsys<sup>®</sup> Anti-p53, and conventional MESACUP™ for the detection of serum anti-p53 antibodies: A multi-institutional studyTakashi Suzuki, Yoko Oshima, Fumiaki Shiratori, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
Breast Cancer (Tokyo, Japan)|October 1, 2024
A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancerYuko Kawai, Aiko Nagayama, Kazuhiro Miyao, et al.
Breast Cancer Research and Treatment|July 10, 2019
Salivary metabolomics with alternative decision tree-based machine learning methods for breast cancer discriminationTakeshi Murata, Takako Yanagisawa, Toshiaki Kurihara, et al.
Neuropsychiatric Disease and Treatment|October 19, 2017
Self-rated cognitive functions following chemotherapy in patients with breast cancer: a 6-month prospective studyRyosuke Kitahata, Shinichiro Nakajima, Hiroyuki Uchida, et al.
Cancer Science|November 1, 2011
Direct inhibition of the transforming growth factor-β pathway by protein-bound polysaccharide through inactivation of Smad2 signalingYoshihiro Ono, Tetsu Hayashida, Ayano Konagai, et al.
Cancer Treatment Reviews|November 12, 2017
The updated network meta-analysis of neoadjuvant therapy for HER2-positive breast cancerAyako Nakashoji, Tetsu Hayashida, Takamichi Yokoe, et al.
Molecular Cancer|June 3, 2014
Bevacizumab terminates homeobox B9-induced tumor proliferation by silencing microenvironmental communicationYoshinori Hoshino, Tetsu Hayashida, Akira Hirata, et al.
Cancer Research|December 4, 2010
The integrin alpha(v)beta(3-5) ligand MFG-E8 is a p63/p73 target gene in triple-negative breast cancers but exhibits suppressive functions in ER(+) and erbB2(+) breast cancersChuanwei Yang, Tetsu Hayashida, Nicole Forster, et al.
Clinical Case Reports|August 28, 2018
IgG4-related mastopathy: A case report and literature reviewTakamichi Yokoe, Tetsu Hayashida, Masayuki Kikuchi, et al.
Surgery|July 2, 2011
The influence of donor age on liver regeneration and hepatic progenitor cell populationsYoshihiro Ono, Shigeyuki Kawachi, Tetsu Hayashida, et al.
Molecular and Clinical Oncology|July 14, 2022
Comparison between a new assay system, Elecsys<sup>®</sup> Anti-p53, and conventional MESACUP™ for the detection of serum anti-p53 antibodies: A multi-institutional studyTakashi Suzuki, Yoko Oshima, Fumiaki Shiratori, et al.
Pageof 9